Cormorant Reports a $42 Million EYPT Purchase

JC Parets
December 7, 2023

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management.

The investment firm reported a purchase of $41,874,150 in EyePoint Pharmaceuticals $EYPT.

MFS Investment Management filed a 13G for QIAGEN N.V. $QGEN revealing an increase in ownership from 9.14% to 10.50%.

Here’s The Hot Corner, with data through December 6, 2023:

The CEO and the CFO of MGP Ingredients $MGPI filed Form 4s revealing a purchase of $109,694 between the two.

In the options market, there was bullish flow in Infinera Corporation $INFN, Five9 Inc $FIVN, and Compania de Minas Buenaventura S.A.A. $BVN.

Stay tuned. We'll be back on Friday with more insider activity.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team

Filed Under